Corporate News

12-Oct-2026, 08:47

Goldline Pharmaceutical Limited submitted a certificate to the Bombay Stock Exchange under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter and half year ended September 30, 2026, received from Bigshare Services Private Limited, its Registrar and Share Transfer Agent. Separately, Bigshare Services Private Limited confirmed that the same regulation is not applicable to Goldline Pharmaceutical Limited for the quarter ended September 30, 2026, as the company’s shares are held in demat form and no requests for dematerialization were received.